Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.4736 USD -1.89% Market Closed
Updated: May 18, 2024

Redhill Biopharma Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Operating Expenses Peer Comparison

Comparables:
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Operating Expenses
$9.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Expenses
-$4.5B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
4%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Operating Expenses
-$271.3m
CAGR 3-Years
-20%
CAGR 5-Years
-12%
CAGR 10-Years
-7%
I
InterCure Ltd
TASE:INCR
Operating Expenses
-₪74.1m
CAGR 3-Years
-2%
CAGR 5-Years
-47%
CAGR 10-Years
-24%
Mediwound Ltd
NASDAQ:MDWD
Operating Expenses
-$19.1m
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Expenses
-₪77.3m
CAGR 3-Years
-17%
CAGR 5-Years
-10%
CAGR 10-Years
0%

See Also

What is Redhill Biopharma Ltd's Operating Expenses?
Operating Expenses
9.6m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Operating Expenses amounts to 9.6m USD.